Statin-Induced Necrotizing Autoimmune Myopathy: Two Case Report

Authors

DOI:

https://doi.org/10.24950/rspmi.1718

Keywords:

Autoimmune Diseases/chemically induced, Hydroxymethylglutaryl-CoA Reductases, Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects, Muscular Diseases/chemically induced, Myositis/chemically induced

Abstract

Statin-induced necrotizing myopathy is an immune- mediated adverse effect that, although rare, should be suspected in the presence of myalgia and rhabdomyolysis, which can persist even after discontinuation of the drug. The prognosis is generally favourable, requiring immunosuppressive therapy in most cases. We present two clinical cases with histological documentation, the second with greater severity requiring therapy with intravenous immunoglobulins. Statins are often prescribed for their role in reducing cardiovascular risk, so clinicians need to be aware of this entity so that treatment can be quickly started, preventing sequelae.

Downloads

Download data is not yet available.

References

Saleh Y, Herzallah K, Hassanein M, Chang HT. Statin-induced necrotizing autoimmune myopathy: An uncommon complication of a commonly used medication. J Saudi Heart Assoc. 2019;31:269-72. doi: 10.1016/j. jsha.2019.08.001.

Stroie OP, Boster J, Surry L. Statin-Induced Immune-Mediated Necrotizing Myopathy: An Increasingly Recognized Inflammatory Myopathy. Cureus. 2020;12:e7963. doi: 10.7759/cureus.7963

Güngör C, Wieshmann UC. Severe statin-i nduced autoimmune myopathy successfully treated with intravenous immunoglobulin. BMJ Case Rep. 2020;13:e234805. doi:10.1136/bcr-2020-234805

Villa L, Lerario A, Calloni S, Peverelli L, Matinato C, De Liso F, et al. Immune- mediated necrotizing myopathy due to statins exposure. Acta Myol. 2018;37:257-62.

Fidalgo C, Mendes A, Cunha R, Rodrigues F. Diagnosis of Statin-Induced Necrotizing Myopathy: Contribution of Anti-HMGCR Antibodies. Acta Med Port. 2022;35:584-7. doi: 10.20344/amp.16181..

Sharma P, Timilsina B, Adhikari J, Parajuli P, Dhital R, Tachamo N. Statin-induced necrotizing autoimmune myopathy: an extremely rare adverse effect from statin use. J Community Hosp Intern Med Perspect. 2019;9:503-6. doi: 10.1080/20009666.2019.1702272

Weeding E, Tiniakou E. Therapeutic management of immune-mediated necrotizing myositis. Curr Treatm Opt Rheumatol. 2021;7:150-60. doi: 10.1007/s40674-021-00174-1.

Published

2023-12-15

How to Cite

1.
Rocha DI, Flores Ribeiro R, Novo A. Statin-Induced Necrotizing Autoimmune Myopathy: Two Case Report. RPMI [Internet]. 2023 Dec. 15 [cited 2024 Nov. 23];30(4):236-40. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1718

Most read articles by the same author(s)